Lack of interleukin-6 expression is not protective against focal central nervous system ischemia

Stroke

Volumn 31, Issue 7, 2000, Pages 1715-1720

  Clark, Wayne M ^a,b   Rinker, Lisa G ^a   Lessov, Nikola S ^a   Hazel, Kristin ^a   Hill, Jennifer K ^b   Stenzel Poore, Mary ^b   Eckenstein, Felix ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Inflammation; Interleukins; Mice, knockout; Stroke

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; INFLAMMATION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE;

EID: 0033933545     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.7.1715     Document Type: Article

References (34)

1. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23:1367-1379.
2. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol. 1992; 263:C1-C16.
3. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J Neurochem. 1991;58:390-392.
4. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. Tumor necrosis factor expression in ischemic neurons. Stroke. 1994;25:1481-1488.
5. Wang XK, Yue T-L, Barone FC, White RF, Gagnon RC, Feuerstein GZ. Concomitant cortical expression of TNFα and IL-1β m RNA following transient focal ischemia. Mol Chem Neuropathol. 1994;23:103-114.
6. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull. 1992;29:243-246.
7. Garcia JH, Liu KF, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol. 1995;147:1477-1486.
8. Coull BM, Beamer NB, Clark WM. Elevated plasma interleukin-6 (IL-6) in acute stroke. Stroke. 1993;24:183. Abstract.
9. Beamer NB, Coull MB, Clark WM, Hazel JS, Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol. 1995; 37:801-805.
10. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci. 1994;122:135-139.
11. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekhom S, Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 1995;26:1393-1398.
12. Clark W, Beamer N, Wynn M, Coull B. The initial acute phase response predicts long-term stroke recovery. J Stroke Cerebrovasc Dis. 1998;7: 128-131.
13. Wang X, Yue T-L, Young PR, Barone FC, Feuerstein GZ. Expression of interleukin-6, c-fos, and zif268 mRNA in rat ischemic cortex. J Cereb Blood Flow Metab. 1995;15:166-171.
14. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Stroke. 1995;92: 1866-1875.
15. Clark W, Rinker L, Lessov N, Hazel K, Eckenstein F. Time course of IL-6 expression in experimental CNS ischemia. Neurol Res. 1999;21: 287-292.
16. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema, I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke. 1986;8:1-8.
17. Clark W, Lessov N, Dixon M, Eckenstein E. Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res. 1997;19: 641-648.
18. Newen G, Kuster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich P. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J Immunol. 1998;161: 6347-6355.
19. Armario A, Hernandez J, Bluethmann H, Hidalgo J. IL-6 deficiency leads to increased emotionality in mice. J Neuroimmunol. 1998;92:160-169.
20. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
21. Hill J, Rinker L, Kulhanek D, Lessov N, Kim S, Clark W, Dixon M, Nishi R, Poore M, Eckenstein F. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res. 1999;820:45-54.
22. Toulmond S, Vige X, Fage D, Benavides J. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett. 1992;144:49-52.
23. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci U S A. 1993;90:10061-10065.
24. Rothwell NJ, Relton JK. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Biobehav Rev. 1992;17:217-227.
25. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines. J Immunol. 1990;144: 129-135.
26. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. Tumor necrosis factor expression in ischemic neurons. Stroke. 1994;25:1481-1488.
27. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke. 1995;26:676-681.
28. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischemic and excitotoxic neuronal damage in the rat. Brain Res Bull. 1992; 29:243-246.
29. Garcia JH, Liu KF, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol. 1995;147:1477-1486.
30. Relton J, Martin D, Thompson R, Russel D. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol. 1996;138:206-213.
31. Chao C, Ehrlich L, Peterson P. IL-1 and TNFα synergistically mediate neurotoxicity. Brain Behav Immun. 1995;374:647-650.
32. Bruce A, Boling W, Kindy M, Peschon J, Kraemer P, Carpenter M, Holtsberg F, Mattson M, Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med. 1996;2:788-794.
33. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, Ciliberto G. IL-6 is required for the development of collagen induced arthritis. J Exp Med. 1998;187:461-468.
34. Carrasco J, Hernandez J, Bluethmann H, Hidalgo J. IL-6 and TNF alpha receptor deficient mice reveal a role of IL-6 and TNF on brain metallothionein regulation. Mol Brain Res. 1988;57:221-234.